Impella to Treat Acute Myocardial Infarct-Related Cardiogenic Shock
Research output: Contribution to journal › Review › Research › peer-review
Documents
- Fulltext
Final published version, 940 KB, PDF document
Acute myocardial infarction complicated by cardiogenic shock (AMICS), is characterized by critically low cardiac output and decreased myocardial contractility. In this situation, a treatment that unloads the myocardium and restores CO without increasing the myocardial oxygen demand is theoretically appealing. Axial flow pumps offer hemodynamic support without increasing myocardial oxygen consumption. Consequently, the use of axial flow pumps, especially the Impella devices, is increasing. It is likely that the SCAI C patient with predominantly left ventricular failure and without prolonged cardiac arrest is the best candidate for these devices. Registry data suggest that pre-PCI Impella may be advantageous to post-PCI placement. However, several gaps in knowledge exist regarding optimal patient selection, futility criteria, timing, weaning and escalation strategy, and until data from adequately sized randomized trials are available, immediate individual evaluation for mechanical circulatory support by a shock team is warranted when a patient is diagnosed with AMICS.
Original language | English |
---|---|
Article number | 2427 |
Journal | Journal of Clinical Medicine |
Volume | 11 |
Issue number | 9 |
ISSN | 2077-0383 |
DOIs | |
Publication status | Published - 2022 |
Bibliographical note
Publisher Copyright:
© 2022 by the authors. Licensee MDPI, Basel, Switzerland.
- acute myocardial infarction, cardiogenic shock, mechanical circulatory support
Research areas
ID: 321471643